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ABSTRACT
In order to explore the genetic relationships
among coxsackie virus B5 strains in Greece, the
nucleotide sequences of the partial VP1 gene in
strains isolated from aseptic cases of meningitis
were determined and compared with those of
strains isolated from other countries. Phylogenet-
ic analysis showed a high degree of divergence
(25%) among Greek strains isolated in different
years, which clustered with high bootstrap val-
ues in a different subgroup of viruses, suggest-
ing that enterovirus types vary with time rather
than geographical distribution. A non-synony-
mous mutation present in the strains of this
study was not observed in other coxsackie virus
B5 strains.
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Enteroviruses (EVs) comprise a large genus in the
Picornaviridae family, with the 65 known human
serotypes delineated into ﬁve species (A–D, plus
the polioviruses) based mostly on their phylo-
genetic relationships [1]. Members of the entero-
virus B species cause a central nervous system
infection, mainly aseptic meningitis, in humans.
Detection of enteroviral RNA in patient speci-
mens is the most rapid and useful method for
laboratory diagnosis and molecular characterisa-
tion of the strains involved [1–7]. In Greece, EVs
are the most common cause of aseptic meningitis.
Sporadic cases, as well as outbreaks, have been
reported, with coxsackie virus B5 being one of the
most predominant serotypes [5,6,8].
Between March 2003 and December 2004, 49
patients (32 males, 17 females; mean age 18 years,
range 21 days to 73 years) with aseptic meningitis
were tested for a probable enteroviral infection.
All 49 patients presented with an acute onset of
fever (> 38C), headache, nausea and vomiting; a
few had stiff necks and one presented with
mental disturbance. Cerebrospinal ﬂuid (CSF)
showed pleiocytosis (38–1300 cells ⁄mm3, mean
462 cells ⁄mm3) with lymphocytosis (50–90%),
moderately elevated levels of protein (18–
180 mg ⁄dL, mean 74 mg ⁄dL) and normal levels
of glucose (33–100 mg ⁄dL, mean 57 mg ⁄dL).
Thirty-seven CSF samples were inoculated into
Hep2 (human epidermoid carcinoma) and RD
(rhabdomyosarcoma) cell lines. Isolates were
typed by neutralisation tests with antiserum pools
(RIVM, National Institute of Public Health and
the Environment, Bilthoven, The Netherlands)
and viral RNA was extracted directly from CSF
samples using a viral RNA extraction kit (Qiagen,
Hilden, Germany). Nested RT-PCR was used to
amplify a 655-bp fragment of the 3¢-end of the
VP1 genome region [4], followed by cycle sequen-
cing reactions with the same primers.
Nineteen of the 49 CSF samples were positive
by RT-PCR, and six strains were isolated in cell
culture. Sequencing and BLAST analysis revealed
coxsackie viruses A9 and B5, and echoviruses 9,
11 and 14, with a predominance of coxsackie virus
B5 and echovirus 11. Two clusters of cases were
distinguishable, i.e., cases observed between
November 2003 and June 2004 caused by cox-
sackie virus B5, and cases observed between June
and December 2004 caused by echovirus 11.
Coxsackie virus B5 was present in four patients,
GR27 ⁄ 03 (November 2003), GR33 ⁄ 03 (December
2003), GR30 ⁄ 04 (May 2004) and GR48 ⁄ 04 (July
2004), aged 62, 11, 45 and 14 years, respectively,
all of whom were residents of northern Greece.
The sequences obtained were submitted to
GenBank with accession numbers DQ095774–
DQ095777, respectively. Four isolates in Hep2
cells from the CSF samples of these patients were
typed as coxsackie virus B by neutralisation tests.
The sequences obtained were aligned with
other sequences retrieved from GenBank, and a
consensus phylogenetic tree was constructed by
the neighbour-joining method using PHYLIP
software [9]. As the other available sequences
were not from the same region of VP1, the
phylogenetic tree was based on a common region
of 279 nucleotides (positions 3004–3283 on the
genome of the prototype strain Faulkner). As
human coxsackie virus B5 is very similar to swine
vesicular disease virus [10], a representative
strain of swine vesicular disease virus HK70
(accession no. AY429470) was also included in
the analysis. Human poliovirus type 1 Mahoney
strain (NC_002058) was used as an outgroup.
Phylogenetic analysis showed that the se-
quence divergence among the coxsackie virus
B5 sequences from this study ranged from 0%
to 2.5% at the nucleotide level. GR27 ⁄ 03 and
GR33 ⁄ 03 were identical; however, there was no
evidence of an outbreak, as the cases were
observed in different months, the patients resi-
ded in different cities > 300 km apart, and no
other similar strains were detected during the
same period. All genomic differences were at
synonymous sites (no amino-acid changes).
However, the divergence from coxsackie virus
B5 strains from southern Greece, isolated in
2001, was much higher (25%), with clustering
with high bootstrap values in two different
subgroups (Fig. 1).
Higher variability was observed in genome
region 3248–3274. Fig. 2 shows the alignment of
amino-acids from representative subgroups in
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this variable region. All strains from the present
study have a lysine (K) in the 82nd amino-acid
position of the prototype strain, which has not
been detected in other coxsackie virus B5 strains;
all other coxsackie virus B5 strains have glutamic
acid (E) at this position, except two Japanese
strains (03-158FCC2 and 8100), which have gluta-
mine. These three amino-acid variations are
hydrophilic, and it is known that this region is
exposed on the virion surface [11]. However,
lysine is a strongly basic, positively-charged
amino-acid, while the free carboxyl group of
glutamic acid makes it acidic and negatively-
charged; glutamine is a polar, amide amino-acid.
The impact of this mutation on viral attachment to
the cell surface is not known.
The genetic distance between the Japanese
strains and the strains of this study was 9%,
which was the closest relationship observed
among the strains analysed. Strain 158FCC2 was
isolated in 2003 in Fukuoka City, on the island of
Kyushu in southern Japan, and strain 8100 was
isolated in 2001 during an epidemic of aseptic
meningitis in the central areas of Nara prefecture,
Japan [12]. Strains clustering in the same sub-
group are a Chinese strain isolated in 2002 during
an outbreak of aseptic meningitis that lasted from
2002 to 2004 (11% difference), and a Finnish strain
isolated in 1982 (12% difference). Sequences from
the meningitis outbreak in Greece during 2001 [6]
cluster in another subgroup, differing from the
strains of this study by 25%, suggesting that EV
types vary with time rather than geographical
distribution. However, different coxsackie virus
B5 strains can also be detected in the same area
during the same year, e.g., Spanish strains isola-
ted in 1997, and Japanese strains isolated in 2003.
The sequence of the 3¢-third of the VP1-coding
sequence can be used for EV taxonomy, identiﬁ-
cation of new EV types, and molecular epidemi-
ology of enteroviral disease outbreaks [2]. It could
also be used to identify recombination break-
points or speciﬁc attributes of pathogenicity [13].
The present study yielded information concerning
genetic variability among enteroviral strains in
Greece, and suggests that there is not a geograph-
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Fig. 1. Consensus phylogenetic tree constructed with cox-
sackie virus B5 sequences, including isolates from the
present study (in bold). Alignments were obtained with
the CLUSTAL W program. The statistical signiﬁcance of
the phylogenies constructed was estimated with the
SEQBOOT program. The 100 datasets obtained were
analysed with the DNADIST program and the parameters
of the Kimura 2 model of nucleotide substitution. The
observed nucleotide distance matrix was then processed
with the NEIGHBOUR program, and the tree was gener-
ated with the CONSENSE program. The numbers at the
nodes represent the percentage of 100 bootstrap replicates
that contained the cluster distal to the node. Bootstrap
values > 60% are indicated.
Fig. 2. Alignment of nine amino-acids in a highly variable
region of VP1. Lysine (K) in the ﬁfth position was present
only in the strains of the present study. Below the
alignments, ‘*’, ‘:’ and ‘.’ denote identity, well-conserved
mutations and conserved mutations, respectively, while no
mark denotes no conserved mutations.
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ical relationship among strains. Thus, Greek
strains from 2003 to 2004 cluster with strains
from Asia of the same period, but differ from
strains isolated in Greece in 2001. Further genetic
studies are needed in order to gain a better insight
into the genetic variability of EV strains and any
relationship with pathogenicity, and to investi-
gate any patterns of recombination, which is a
frequent event during EV evolution.
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ABSTRACT
Seven genetically related Proteus mirabilis clinical
isolates from a hospital in Thessaloniki, Greece,
exhibited decreased susceptibility to imipenem
and carried a blaVIM-1 metallo-b-lactamase gene.
PCR mapping revealed that blaVIM-1 was part of
a class 1 integron that was probably located in
the chromosome and also included the aacA7,
dhfr and aadA genes. This is the ﬁrst description
of the blaVIM-1 metallo-b-lactamase gene in
P. mirabilis.
Keywords blaVIM-1 gene, carbapenem resistance,
integron, metallo-b-lactamase, PCR mapping, Proteus
mirabilis
Original Submission: 12 September 2005; Revised
Submission: 10 November 2005; Accepted: 11
December 2005
Clin Microbiol Infect 2006; 12: 691–694
10.1111/j.1469-0691.2006.01489.x
Corresponding author and reprint requests: A. C. Vatopoulos,
Department of Microbiology, National School of Public Health,
196 Alexandras Ave., Athens 11521, Greece
E-mail: avatopou@nsph.gr
Research Notes 691
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 12, 672–694
